Bonnie L. Bassler - Sep 8, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/** Bonnie L. Bassler
Stock symbol
REGN
Transactions as of
Sep 8, 2022
Transactions value $
-$999,689
Form type
4
Date filed
9/12/2022, 04:31 PM
Previous filing
Jun 30, 2022
Next filing
Sep 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $501K +1.28K +118.21% $391.92 2.36K Sep 8, 2022 Direct F1
transaction REGN Common Stock Sale -$902K -1.28K -54.17% $705.00 1.08K Sep 8, 2022 Direct F1, F2
transaction REGN Common Stock Options Exercise $501K +1.28K +118.21% $391.92 2.36K Sep 8, 2022 Direct F1
transaction REGN Common Stock Sale -$879K -1.28K -54.17% $686.99 1.08K Sep 8, 2022 Direct F1
transaction REGN Common Stock Options Exercise $229K +609 +56.28% $376.69 1.69K Sep 9, 2022 Direct F1
transaction REGN Common Stock Sale -$451K -609 -36.01% $741.00 1.08K Sep 9, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -609 -49.96% $0.00 610 Sep 9, 2022 Common Stock 609 $376.69 Direct F1, F3
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.28K -24.99% $0.00 3.84K Sep 8, 2022 Common Stock 1.28K $391.92 Direct F1, F3
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.28K -33.32% $0.00 2.56K Sep 8, 2022 Common Stock 1.28K $391.92 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 1,279 shares of Company stock on September 8, 2022 at prices ranging from $705.00 to $705.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 8, 2022 at each separate price.
F3 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.